Crescent Biopharma, Inc.CBIONASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Year-over-year operating income growth rate
Latest
-75.08%
↓ 167% below average
Average (9y)
-28.14%
Historical baseline
Range
High:25.29%
Low:-149.62%
CAGR
+19.8%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | -75.08% |
| 2023 | 17.15% |
| 2022 | 25.29% |
| 2021 | -23.18% |
| 2020 | 16.09% |
| 2019 | -19.19% |
| 2018 | -51.79% |
| 2017 | -6.33% |
| 2016 | -149.62% |
| 2015 | -14.77% |